← brief for 2026-09-17 · Slowing decline

Pharmacological intersections between type 2 diabetes and cancer: metabolic crosstalk, antidiabetic therapies, and clinical implications.

Paper No results yet Peer reviewed

Key takeaways

This is a review article that summarizes what is known about the link between type 2 diabetes and cancer. It looks at how diabetes drugs might affect cancer risk. It does not report new results from a single study. It is a summary of existing research.

Who did this work

Liu D · Xie D · Che X · Li X · Xu W · Wu G

Source

Paper · PubMed, the drug frontier · 2026 Sep 17
https://pubmed.ncbi.nlm.nih.gov/42753877/